COMPANY PROFILE

Ablative Solutions

Explore full profile

A medical device firm that offers an alternative to surgical renal denervation for treating hypertension

Wakefield, United StatesFounded 2011Biotech & Life Sciences

Valuation $500M–1B Last recorded · 2022

Headcount <100 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About Ablative Solutions

Ablative Solutions, Inc. focuses on developing innovative medical devices aimed at reducing high blood pressure, specifically targeting patients with uncontrolled hypertension. The company's core product, the Peregrine System Kit, is currently under investigation to evaluate its safety and effectiveness in clinical trials. Ablative Solutions operates in the medical device market, serving healthcare providers and patients who struggle with hypertension that is resistant to conventional treatments. The business model revolves around the development, clinical testing, and eventual commercialization of their proprietary medical devices. Revenue is anticipated to be generated through the sale of these devices to hospitals, clinics, and healthcare providers once regulatory approvals are obtained.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2011
Headquarters: Wakefield, United States
Employees: 18
Open positions: None listed
Dealroom signal: 37.3/100
Industry: Health
Sub-industry: BioTechnology, Medical Devices
Sector: Biotech & Life Sciences, Biotechnology, Biomedical, Spinout, Biotech and Pharma, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

10 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
LATE VCOther financing	Dec 2025	$0	—	Undisclosed	↗
CONVERTIBLEOther financing	Feb 2024	$29M	—	Undisclosed	↗

Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

Ablative Solutions website traffic

Latest recorded traffic for Ablative Solutions is 690 monthly website visits, down 46.9% over the last three months. Ablative Solutions's team grew 12.5% over the past year.

Latest monthly visits690 3-month web change-46.9% 1-year team growth+12.5%

Monthly website visitsApr 2016–Jun 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
ASAdalid SciencesAdvanced lipid nanoparticle technology enhancing genomic medicine through innovative drug delivery systems	Prague, Czechia	Operational	16	$8.6M	$35M
BEBexorgTransforming brain research with molecular platforms to combat neurological diseases	New Haven, United States	Operational
XBXellar BiosystemsAccelerating drug discovery through human-mimetic organ-on-a-chip technology, high-fidelity 3D disease models, and AI-powered spatiotemporal profiling.	Boston, United States	Operational
FBFOx BiosystemsFox biosystems produces fiber-optic biosensor instruments	Diepenbeek, Belgium	Operational
SBSpear BioOffers opportunities for better detections with less invasive biospecimen collection	Woburn, United States	Operational
RERetinaLogikPreventing blindness by making eye exams accessible, affordable, and detecting conditions sooner	Calgary, Canada	Operational
NENeuro42Portable, user-friendly MRI platform with AI and robotics capabilities for screening, diagnosis, and live image-guided interventions, revolutionizing healthcare with intelligent procedural planning and predictive analysis	San Francisco, United States	Operational
PUPulseMedicaBuilding revolutionary technology to image and treat vitreoretinal disease	Edmonton, Canada	Operational